ZA764868B - Novel pharmaceutical preparation adapted for oral administration - Google Patents

Novel pharmaceutical preparation adapted for oral administration

Info

Publication number
ZA764868B
ZA764868B ZA764868A ZA764868A ZA764868B ZA 764868 B ZA764868 B ZA 764868B ZA 764868 A ZA764868 A ZA 764868A ZA 764868 A ZA764868 A ZA 764868A ZA 764868 B ZA764868 B ZA 764868B
Authority
ZA
South Africa
Prior art keywords
oral administration
pharmaceutical preparation
novel pharmaceutical
preparation adapted
novel
Prior art date
Application number
ZA764868A
Other languages
English (en)
Inventor
Vies J Van Der
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA764868B publication Critical patent/ZA764868B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA764868A 1975-08-27 1976-08-12 Novel pharmaceutical preparation adapted for oral administration ZA764868B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7510104A NL7510104A (nl) 1975-08-27 1975-08-27 Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.

Publications (1)

Publication Number Publication Date
ZA764868B true ZA764868B (en) 1977-07-27

Family

ID=19824362

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA764868A ZA764868B (en) 1975-08-27 1976-08-12 Novel pharmaceutical preparation adapted for oral administration

Country Status (17)

Country Link
US (1) US4083973A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5231063A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU508727B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE845613A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1092025A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2638507A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2321892A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1563302A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR70296B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU176743B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE44533B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL50274A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU75648A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7510104A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ181865A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH12363A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA764868B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
FR2427100A1 (fr) * 1978-06-02 1979-12-28 Kali Chemie Pharma Gmbh Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
US5140021A (en) * 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome
US5208032A (en) * 1988-07-15 1993-05-04 Rutgers, The State University Of New Jersey Increasing the growth of turkeys using implant of 19-nortestosterone
WO1995025504A1 (en) * 1994-03-18 1995-09-28 Pharmavene, Inc. Emulsified drug delivery systems
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US6011027A (en) * 1999-02-18 2000-01-04 Lpj Research, Inc. Use of 19-nor-4-androstenediol to increase 19-nortestosterone levels in humans
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
AU2003231126A1 (en) 2002-04-25 2003-11-10 Banner Pharmacaps, Inc. Chewable soft capsule
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
ES2258694T3 (es) * 2003-11-11 2006-09-01 Mattern, Udo Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales.
CN1257711C (zh) * 2003-12-05 2006-05-31 石药集团中奇制药技术（石家庄）有限公司 丁苯酞软胶囊及其制备工艺
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
FI3456329T3 (fi) 2005-10-12 2025-02-27 Besins Healthcare Lu Sarl Parannettu testosteronigeeli ja käyttömenetelmä
RU2480208C2 (ru) 2006-10-04 2013-04-27 М Унд П Патент Акциенгезелльшафт Система доставки с контролируемым высвобождением для назального применения нейротрансмиттеров
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
RU2708238C2 (ru) 2014-06-17 2019-12-05 Мерк Шарп и Доум Б.В. Стабильные составы тестостерона ундеканоата

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998423A (en) * 1958-02-25 1961-08-29 Organon Esters of 19-nortestosterone
US3016388A (en) * 1959-06-30 1962-01-09 Organon New esters of 19-nor-testosterone
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
IL50274A0 (en) 1976-10-31
GR70296B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-09-06
IE44533L (en) 1977-02-27
HU176743B (en) 1981-05-28
AU508727B2 (en) 1980-04-03
AU1698076A (en) 1978-02-23
FR2321892B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-05-25
IE44533B1 (en) 1981-12-30
IL50274A (en) 1980-11-30
LU75648A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-03-31
DE2638507A1 (de) 1977-03-03
NL7510104A (nl) 1977-03-01
PH12363A (en) 1979-01-29
GB1563302A (en) 1980-03-26
BE845613A (fr) 1977-02-28
FR2321892A1 (fr) 1977-03-25
JPS5231063A (en) 1977-03-09
US4083973A (en) 1978-04-11
NZ181865A (en) 1978-12-18
CA1092025A (en) 1980-12-23

Similar Documents

Publication Publication Date Title
GR58257B (en) Novel pharmaceutical preparation adapted for oral administration
ZA764868B (en) Novel pharmaceutical preparation adapted for oral administration
PH12959A (en) Preparation of pharmaceutical unit dosage form
ZA741963B (en) Oral drug preparations
ZA7671B (en) Pharmaceutical composition
ZA751007B (en) Oral pharmaceutical preparation
GB1539076A (en) Process for preparing preparations for oral administration
JPS5272829A (en) Pharmaceutical composition
NZ180321A (en) Sustained release pharmaceutical preparation
IL51096A0 (en) Novel pharmaceutical dosage form
IL48806A0 (en) New biphenyloxy derivatives,their preparation and pharmaceutical compositions containing them
AU504182B2 (en) Pharmaceutical dosage forms
HK42382A (en) Pharmaceutical compositions
GB1549171A (en) Pharmaceutical formulations containing hydrocy bezophenonederivatives
IL49758A0 (en) Novel phenothiazine derivatives,their preparation and pharmaceutical compositions containing them
IL50816A0 (en) Novel 6-aryl-s-triazolo(4,3a)pyrido(2,3-f)(1,4-diazepines),their preparation and pharmaceutical compositions containing them
AU1306576A (en) Pharmaceutical formulation
IL48791A0 (en) Novel penicillin derivatives,their preparation and pharmaceutical compositions containing them
GB1550359A (en) Antibiotic compositions for oral administration
ZA767215B (en) Pharmaceutical compositions
ZA761880B (en) New pharmaceutical compositions
PH13439A (en) Method of preparing solid pharmaceutical unit dosage form
ZA761012B (en) Pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
GB1367608A (en) Oral pharmaceutical dosage form